Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystal form of anhydrous 7-(1.alpha.,5.alpha.,6.alpha.!-6-amino-3-azabicyclo3.1.0!hex-3-yl)-6-f luoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt

Crystal form of anhydrous 7-(1.alpha.,5.alpha.,6.alpha.!-6-amino-3-azabicyclo3.1.0!hex-3-yl)-6-f luoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt

US Patent 5763454 · Granted Jun 9, 1998

Estimated economic value: $336,309,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrat2009
Process for the preparation of 1,3-substituted indenes2007
Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,72006
Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-ch2006
Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinam2005
Citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,2004
Preparation of sodium-hydrogen exchanger type-1 inhibitors2004
N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anh2004
Processes and intermediates for preparing anti-cancer compounds2002
Process for preparing trovafloxacin acid salts2002
Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring sys2002
Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring sys2002